The commercial platform for healthcare

Sell more. Waste less.

We help pharmaceutical and medical device sales teams find, target, and close the right accounts faster.

Explore Rare.MonitorBook a demo

Real customer outcomes.

The numbers speak for themselves.

+106%

Increase in prospect engagement

42%

Conversion rate on prospect targeting

5 hrs

Saved per week per rep on prospect research

+23.6%

Monthly revenue uplift after switching to Rare.

Source: Rare.Monitor users 2025-2026.

Trusted by the best in the business

"The Rare. strength is a combination of large data samples, strong data analytics & insight generation capabilities and, importantly, ability to listen to the customer needs and give us clear options based on that. This makes Rare: a high quality thought partner."

Anton Petrov

Brand Director, L'Oreal

"I have worked with Rare.Monitor during my previous and current role. It has provided unparalleled access to market insights for both strategic planning and supporting my teams to expand their customer base. The team at Rare. are super responsive to feedback and provide excellent support to optimise the tools. We also use the data to support our existing clients with business planning by looking at their local competitive landscape to help them find new opportunities. I would have loved access to this when I was a sales rep, now I get to empower my team with high quality data and remove the time consuming task of hunting for new prospects on Google and Socials instead."

Natalie Colbourne

Director of Commercial Programmes and Strategy, Establishment Labs

"Their methodology was robust throughout and I was very impressed by their attention to detail and implementation plans for rollout to the broader team. I highly recommend partnering with the Rare: team!"

Isabel Diez-Sevilla

Business Insights & Analytics Manager, Daiichi Sankyo UK

"Proud to see SUNEKOS among the top 5 most mentioned injectable brands in the UK. A result that reflects the professionalism, perseverance, and scientific integrity that define our work every day at Professional Dietetics. Great Analysis!"

Tiziano Cameroni

C.E.O. & Co-Owner, Professional Dietetics

L'Oreal
Alibreo
MAP Health
NHS
The London Clinic
Galderma
Vivacy
Align Technology
Alma
Members of
  • MRS
  • ABPI
  • BHBIA

Find prospects. Track accounts. Close faster.

Rare.Monitor gives your commercial team one place to find new prospects, manage accounts, and track what's working, across over 160,000 UK and Ireland healthcare providers. Live market data and account management built into the same workflow, so your reps act on insight the moment they see it.

Find prospects. Track accounts. Close faster.

Three things commercial teams notice within the first month

Why RARE.

01

Built for commercial teams in private healthcare

Not a generic CRM, not a research subscription. Rare.Monitor mirrors how pharma and medical device teams actually work: targeting accounts, prioritising opportunities, reading the channel.

02

Live data, not last year's report

The provider dataset behind Rare.Monitor refreshes daily.

03

One source of truth

Prospecting, account management, and live market intelligence on UK private healthcare. No system-hopping between tools.

Ready to double your revenue?

Our clients have. Book a demo and we'll show you how Rare.Monitor helped one team increase rep revenue by 98%.

Book a demoRead the full story →

Latest

Insights

Ten of England's 42 NHS areas fall below average on physiotherapy clinic provision and above average on NHS orthopaedic waits at the same time. Lincolnshire is the only one in the worst quarter of the country on both. Source: Rare.Monitor, June 2026; NHS England Referral to Treatment statistics, March 2026.
Market insights Read now

Where England's physiotherapy supply is thinnest and NHS orthopaedic waits are longest

Deciding where England needs a new musculoskeletal clinic takes more than one metric. Put together how thinly physiotherapy is spread with how long people wait for NHS orthopaedic treatment, and ten NHS areas stand out. Lincolnshire stands out most: among the fewest clinics per head in the country, and among the longest waits.

17 July 2026

Card hero for the Invisalign English dental market article. 54% headline stat in Bold Blue on Ink background, Inter 900 display title, JetBrains Mono technical labels. Wordmark rendered as RARE with a Bold Blue period sitting at the baseline of the E, per brand rules. Source: Rare.Monitor, June 2026.
Market stats Register to read

English Dental Market: Invisalign Brand Penetration, June 2026

54% of English dental practices name Invisalign on their website in June 2026. The brand is one of the most mentioned manufacturers in the UK healthcare market tracked by Rare.Monitor. Five English chains name Invisalign on every site Rare.Monitor has indexed. Based on Rare.Monitor’s audit of 3,463 English dental practices across 33 ITL2 regions.

25 June 2026

33.4% of open referrals on the NHS community weight-management waiting list have been open more than a year. NHS England CHS, Feb 2026, six-region baseline excl. Midlands.
Blog Read now

The NHS community weight-management list is ageing, not clearing

Almost a third of open referrals on the NHS Community Health Services waiting list for adult weight management and obesity have been open for more than a year, according to NHS England's February 2026 return. The list is small (5,930 open referrals nationally, sourced from CSDS) and this piece signposts what the data does and does not cover: it is not the RTT list quoted by the BMA, and it excludes tier 3 and tier 4 specialist care, the NHS Digital Weight Management Programme, and the NHS and private GLP-1 markets. Within that narrow scope, the queue is ageing sharply and provision is concentrated in one region.

17 June 2026

View all insights →